You are here: Home current partnering biomarin pharmaceuticals partnering 2009 2014

Page not found

×

Error message

The page you requested does not exist. For your convenience, a search was performed using the query current partnering biomarin pharmaceuticals partnering 2009 2014.
Your search for "" gave back 1102162 results.

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H1 2018

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2018
Price: USD 3,500.00

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021 Summary Somatostatin Receptor Type 4 (SSTR4) pipeline Target constitutes close to 5...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
June 2021
Price: USD 3,500.00

Somatostatin Receptor Type 4 - Pipeline Review, H2 2020

Somatostatin Receptor Type 4 - Pipeline Review, H2 2020 Summary Somatostatin Receptor Type 4 (SSTR4) - Somatostatin receptor type 4 is a protein...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
October 2020
Price: USD 3,500.00

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
August 2021
Price: USD 2,000.00

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
August 2022
Price: USD 3,500.00

Friedreich Ataxia - Pipeline Review, H2 2020

Friedreich Ataxia - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
September 2020
Price: USD 2,000.00

Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020

Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
October 2020
Price: USD 2,000.00

Phenylketonuria (PKU) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Phenylketonuria (PKU) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2022
Price: USD 2,000.00

Myasthenia Gravis - Pipeline Review, H1 2019

Myasthenia Gravis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
February 2019
Price: USD 2,000.00

Friedreich Ataxia - Pipeline Review, H1 2020

Friedreich Ataxia - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2020
Price: USD 2,000.00

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019 Summary Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) pipeline Target...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
June 2019
Price: USD 3,500.00

Myasthenia Gravis - Pipeline Review, H2 2020

Myasthenia Gravis - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
July 2020
Price: USD 2,000.00

Myasthenia Gravis - Pipeline Review, H1 2020

Myasthenia Gravis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
January 2020
Price: USD 2,000.00

Myasthenia Gravis (Immunology) - Drugs in Development, 2021

Myasthenia Gravis (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2021
Price: USD 2,000.00

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct'...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
November 2021
Price: USD 2,000.00

Contact Us for Custom Market Research Solutions

 

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected